Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27−0.01 (-3.74%)
Close on Nov 20, 2026Market cap $2.89MP/E –Yield –
Gelteq free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -A$5.52M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -A$5.52M | – |
| FY2024 | Jun 30, 2024 | -A$1.07M | – |
| FY2023 | Jun 30, 2023 | -A$1.80M | – |
See a number that looks wrong?